Description of the medicine: Magurlit (Magurlit)

Magurlit *.

Granules (pink color) in 2 g packs containing potassium citrate (0.794 g), sodium citrate (0.723 g), citric acid (0.27 g), magnesium citrate (0.18 g), pyridoxine hydrochloride (0.008 g) .

The drug is designed to shift the pH of the urine towards the alkaline reaction (mainly under the influence of citrate ions), as well as to inhibit the formation and dissolution (under the influence of magnesium ions and pyridoxine) of stones consisting of calcium oxalate, and also from a mixture of uric acid and calcium oxalate .

Apply magurlite to dissolve and prevent the re-formation of urinary stones in cases with persistent acidity of urine (pH less than 5, 5).

Is taken internally. The average dose for adults is 6-8 g per day (2 g in the early morning, 2 g in the afternoon and 2 or 4 g in the late evening). Wash with water (or fruit juice).

To further refine the dose, daily urine pH is determined using the indicator paper attached to the preparation, comparing the color with the attached color scale; The pH of fresh urine, determined in the morning, in the afternoon and in the evening before taking the drug, should, with the correct dosage, be in the range of 6, 0 to 6, 7 - 7, 0. The excess of this value should be avoided, since with an alkaline urine reaction (pH Above 7, 0) can form phosphate stones. To maintain the pH at this level, the dose of the drug must be selected individually.

The drug can be used continuously - continuously or intermittently.

Treatment should be carried out under medical supervision.

Contraindications: infected urine, circulatory insufficiency (due to the large amount of sodium and potassium in the preparation.). In the course of treatment, there may be disturbances in the activity of the gastrointestinal tract, usually passing without stopping the course of treatment.

To facilitate the removal of stones from the urinary tract is recommended simultaneously with the intake of magurlite (as well as bleamaren and soluran) increased injection of liquid into the body. In the absence of contraindications from the side of the cardiovascular system and the kidneys, the patient should take at least 1, 5 - 2 liters of liquid (mineral alkaline water, tea, fruit juices).

Form release: in packages of 2 g of the drug in a package of 100 pieces with the application of indicator papers, a color scale and tweezers.

Produced in Hungary.